Medical devices, healthcare technology and the business of care
PMA approval · P150035

Aveir VR Leadless System

ABBOTT MEDICAL · Decision date Mar 31, 2022

MEDTECHLEDGER EXPLANATIONP150035

What did the FDA approve?

The FDA database entry for P150035 records an approval decision dated March 31, 2022, for the Aveir Leadless Pacemaker, Aveir Delivery System Catheter, and Aveir Link Module. The applicant is listed as Abbott Medical, and the product code is PNJ under the cardiovascular specialty.

The decision statement describes approval for these three named components. The entry does not state whether this action is an original PMA approval or a supplement, and no supplement type or reason is provided. The source does not include clinical data, safety findings, or effectiveness conclusions.

FDA approval order statement

Approval for the Aveir Leadless Pacemaker, Aveir Delivery System Catheter, and Aveir Link Module.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Mar 31, 2022

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P150035
Regulatory pathway
Premarket approval application
Product code
PNJ
Decision code
APPR
Decision date
Mar 31, 2022
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Leadless pacemaker.

Product code
PNJ
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P150035 received

    Application receipt date recorded by FDA.

  2. P150035 · FDA decision

    APPR

  3. P150035/S042 · Related supplement

    AVEIR VR Real-World Evidence Study

Timeline entries are records held by MedtechLedger for P150035. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150035

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 21, 2026FDA

Explore the linked device profile

Other records with product code PNJ

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA supplementSep 8, 2026FDA
Medtronic, Inc.PMA approvalApr 6, 2016FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
15900 Valley View Ct., Sylmar, CA, 91342

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records